Efficacy of a paracetamol and caffeine combination in the treatment of the key symptoms of primary dysmenorrhoea

Current Medical Research and Opinion

Volumn 23, Issue 4, 2007, Pages 841-851

  Ali, Zahid ^a   Burnett, I ^a   Eccles, R ^b   North, M ^a   Jawad, M ^b   Jawad, S ^b   Clarke, G ^a   Milsom, I ^c  

^a GLAXOSMITHKLINE   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Backache; Cramping; Menstrual; Pain; Women

Indexed keywords

CAFFEINE; CONTRACEPTIVE AGENT; CYPROTERONE ACETATE; ETHINYLESTRADIOL; IBUPROFEN; PARACETAMOL; PLACEBO; PROGESTERONE;

ABDOMINAL CRAMP; ANALGESIA; ARTICLE; BACKACHE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSMENORRHEA; FATIGUE; FEMALE; HEADACHE; HUMAN; INCIDENCE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MONOTHERAPY; NAUSEA;

ACETAMINOPHEN; ADOLESCENT; ADULT; ANALGESICS, NON-NARCOTIC; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DYSMENORRHEA; FEMALE; HUMANS; PLACEBOS; TREATMENT OUTCOME;

EID: 34247390447     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079907X182239     Document Type: Article

References (29)

1. Andersch B, Milsom I. An epidemiologic study of young women with dysmenorrhea. Am J Obstet Gynecol 1982;44:655-60
2. Coco AS. Primary dysmenorrhea. Am Fam Physician 1999;60:489-96
3. Hillen TIJ, Grbavac SL, Johnston PJ, et al. Primary dysmenorrhea in young western Australian women: prevalence, impact, and knowledge of treatment. J Adolesc Health 1999; 25:40-5
4. Teperi J, Rimpela M. Menstrual pain, health and behaviour in girls. Soc Sci Med 1989;29:163-9
5. Burnett MA, Antao V, Black A, et al. Prevalence of primary dysmenorrhea in Canada. JOGC 2005;27:765-70
6. Dawood MY. Dysmenorrhea. Clin Obstet Gynecol 1990;33:168-78
7. Sundell G, Milsom I, Andersch B. Factors influencing the prevalence and severity of dysmenorrhea in young women. Br J Obstet Gynaecol 1990;97: 588-94
8. Dawood MY. Ibuprofen and dysmenorrhea. Am J Med 1984;77:87-94
9. Deligeoroglou E. Dysmenorrhea. Ann N Y Acad Sci 2000;900:237-44
10. Milsom I, Andersch B. Effect of ibuprofen, naproxen sodium and paracetamol on intrauterine pressure and menstrual pain in dysmenorrhoea. Br J Obstet Gynaecol 1984;91:1129-35
11. Prescott LF. The therapeutic use of paracetamol. Paracetamol: A Critical Bibliographic Review. London: Taylor and Francis, 2001
12. Prescott LF. Pharmacological actions of paracetamol. Paracetamol: A Critical Bibliographic Review. London: Taylors and Francis, 2001
13. Campbell MA, McGrath PJ. Use of medications by adolescents for the management of menstrual discomfort. Arch Pediatr Adolesc Med 1997;151:905-13
14. Zhang WY, Po LW. Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review. Br J Obstet Gynaecol 1998;105:780-9
15. Milsom I, Minic M, Dawood MY, et al. Comparison of the efficacy and safety of non-prescription doses of naproxen and naproxen sodium with ibuprofen, acetaminophen, and placebo in the treatment of primary dysmenorrhea: a pooled analysis of five studies. Clin Ther 2002;24:1384-400
16. Migliardi JR, Armellino JJ, Friedman M, et al. Caffeine as an analgesic adjuvant in tension headache. Clin Pharmacol Ther 1994;56:576-86
17. NSAIDs for primary dysmenorrhoea. Bandolier evidence based medicine journal, 2004. http://www.jr2.ox.ac.uk/bandolier/band120/b120-3.html [Last accessed 13 October 2006]
18. Akerlund M, Stromberg P. Comparison of ketoprofen and naproxen in the treatment of dysmenorrhea, with special regard to the time of onset of pain relief. Curr Med Res Opin 1989;11:485-90
19. Marchini M, Tozzi L, Bakshi R, et al. Comparative efficacy of diclofenac dispersable 50 mg and ibuprofen 400 mg in patients with primary dysmenorrhea. A randomized, double blind, within patient, placebo controlled study. Int J Clin Pharmacol Ther 1995;33:491-7
20. Pickering G, Loriot MA, Libert F, et al. Analgesic effect of acetaminophen in humans: first evidence of a central serotonergic mechanism. Clin Pharmacol Ther 2006;79:371-8
21. 2α in a randomized, double blind, crossover treatment with placebo, acetaminophen, and ibuprofen in primary dysmenorrhea. Am J Obstet Gynecol 2007;196:35.el-35.e5
22. Laska EM, Sunshine A, Mueller F, et al. Caffeine as an analgesic adjuvant. JAMA 1984;251:1711-18
23. Renner B, Clarke G, Grattan T, et al. Analgesic effects of paracetamol in comparison to its combination with caffeine. J Clin Pharmacol 2003;43:1038
24. Sawynok J. Pharmacological rationale for the clinical use of caffeine. Drugs 1995;49:37-50
25. Smith AP. Effects of caffeine on human behaviour. Food Chem Toxicol 2002;40:1243-55
26. Feinstein AR, Heinemann LA, Dalessio D, et al. Do caffeine containing analgesics promote dependence? A review and evaluation. Clin Pharmacol Ther 2000;68:457-67
27. Zhang WY. A benefit-risk assessment of caffeine as an analgesic adjuvant. Drug Safety 2001;24:1127-42
28. Dews PB, O'Brien CP, Bergman J. Caffeine: behavioural effects of withdrawal and related issues. Food Chem Toxicol 2006;40:1257-61
29. Slap GB. Menstrual disorders in adolescence. Best Practice & Research. Clin Obstet Gynecol 2003;17:75-92